2024 ESMO Annual Meeting Insights Hub
D

ESMO 2024 Insights: Nal-IRI/LV5-FU vs. Paclitaxel as 2L Therapy in Metastatic Esophageal SCC - OESIRI-PRODIGE 62 Study

By 2024 ESMO Annual Meeting Insights Hub FEATURING David Tougeron
By 2024 ESMO Annual Meeting Insights Hub FEATURING David Tougeron
3 views
September 27, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
09:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancer…

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
22:49
Integrity CE

Recent Updates in Upper Gl Cancers

Feat. S. Mukherjee
17:23
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta
09:58
Elizabeth Smyth

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Feat. R. Sundar
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
08:19
COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroeso…

Feat. E. Smyth, S. Klempner, J. Seligmann, D. Modest
11:57
COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Ca…

Feat. M. Socinski, P. R. Galle, S. Dawood, E. Smyth, S. Klempner
06:53
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
04:01
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tisleliz…

Feat. H. Yoon
15:47
Integrity CE

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

Feat. K. Bever, R. Voong, J. Hernandez, S. Klempner
35:26
Debbie's Dream Foundation

Gastroesophageal Cancer Updates From 2024 Summer Conferences

Feat. S. Klempner
18:42
UChicago Medicine Annual Practice Updates in Hematology and Oncology

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Canc…

Feat. M. Amin
26:40
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesoph…

Feat. A. Shreenivas, S. Chakrabarti
33:42
Yale Cancer Center

Year in Review - Systemic Therapies for Metastatic Gastroesophageal …

Feat. J. Lacy
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
23:39
OncoAlert

Year in Review: Gastric, Esophageal, & Liver Cancers

Feat. S. Gill
57:57
Hope for Stomach Cancer

1L Therapy for HER2+ Stage 4 Gastroesophageal Cancers

Feat. D. Catenacci
06:32
Nebraska Oncology Society

ASCO® 2024 Review: Updates in the Management of Resectable Esophagea…

Feat. R. Safyan
19:29
Total Health

Case-Based Clinical Updates in GI Cancer: 56 y/o Male With GEJ Adeno…

Feat. R. Mehta, M. Tejani, K. Blue